2025年3月16日 · Evolocumab (brand name Repatha) is a PCSK9 inhibitor used for hypercholesterolemia (high cholesterol) and cardiovascular risk reduction. It is given by …

Evolocumab, [6] sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab is a fully human …

2025年3月12日 · Repatha (evolocumab) is a PCSK9 inhibitor used to lower high cholesterol alongside dietary changes and to reduce the risk of major cardiovascular events in those with …

2025年2月1日 · It is also used to reduce the risk of death, heart attack, stroke, unstable angina (chest pain) requiring hospitalization, or certain types of heart surgery in patients with existing …

2017年5月4日 · Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by …

lower bad (LDL) cholesterol and reduce your risk of heart attack. This is Sam. He does not have high bad cholesterol. He also performs tasks perfectly. When trying to lower your cholesterol, …

Adjunct to diet, alone or in combination with other lipid-lowering therapies (eg, statins), for treatment of primary hyperlipidemia, including heterozygous familial hyperlipidemia (HeFH), to …

2025年1月6日 · Learn about the side effects of evolocumab, from common to rare, for consumers and healthcare professionals.

2024年5月21日 · Repatha (evolocumab) is commonly used for the following conditions. To lower the risk of heart attack, stroke, and certain types of heart surgery in people with heart disease

Evolocumab is a prescription medication used to reduce the risk of myocardial infarction, stroke, coronary revascularization, and to treat primary hyperlipidemia and homozygous familial …